FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Victor Villemagne

Research Profile

Procedures

Disorders

Anatomy

Brain

Chemicals & Drugs

Concepts & Ideas

Living Beings

Papio

Activities & Behaviors

Image Processing, Computer-Assisted

Co-author Network

Publications

TOP 3
Yen Ying Lim; Ralph N Martins; Colin L Masters; Christopher C Rowe; Albrecht Stöffler; Cassandra E I Szoeke; Victor L Villemagne; David Ames; Tim Ashwood; Ashley Bush; David Darby; Kathryn A Ellis; Karra Harrington; Judith Jaeger; Rebecca Lachovitzki; Paul Maruff
Three-Month Stability of the CogState Brief Battery in Healthy Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease: Results from the Australian Imaging, Biomarkers, and Lifestyle-Rate of Change Substudy (AIBL-ROCS).
Christopher C Rowe; Victor L Villemagne
Amyloid Imaging with PET in Early Alzheimer Disease Diagnosis.
Victor L Villemagne; David Ames; Pierrick Bourgeat; Belinda Brown; Samantha Burnham; Kathryn A Ellis; S Lance Macaulay; Ralph Martins; Paul Maruff; Colin L Masters; Christopher C Rowe; Olivier Salvado; Cassandra E I Szoeke
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Victor Villemagne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yen Ying Lim; Ralph N Martins; Colin L Masters; Christopher C Rowe; Albrecht Stöffler; Cassandra E I Szoeke; Victor L Villemagne; David Ames; Tim Ashwood; Ashley Bush; David Darby; Kathryn A Ellis; Karra Harrington; Judith Jaeger; Rebecca Lachovitzki; Paul Maruff
Three-Month Stability of the CogState Brief Battery in Healthy Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease: Results from the Australian Imaging, Biomarkers, and Lifestyle-Rate of Change Substudy (AIBL-ROCS).
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2013;28(4):320-30.
2013: Christopher C Rowe; Victor L Villemagne
Amyloid Imaging with PET in Early Alzheimer Disease Diagnosis.
The Medical clinics of North America 2013;97(3):377-98.
2013: Victor L Villemagne; David Ames; Pierrick Bourgeat; Belinda Brown; Samantha Burnham; Kathryn A Ellis; S Lance Macaulay; Ralph Martins; Paul Maruff; Colin L Masters; Christopher C Rowe; Olivier Salvado; Cassandra E I Szoeke
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Lancet neurology 2013;12(4):357-67.
2013: Andrew D Watt; Michelle Fodero-Tavoletti; Lin Wai Hung; Craig A Hutton; Timothy Johanssen; Woan Mei Kok; Colin L Masters; Catriona A McLean; Keyla A Perez; Alan Rembach; Nicki A Sherrat; Victor L Villemagne; Kevin J Barnham
Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples.
Acta neuropathologica 2013;125(4):549-64.
2013: Christopher C Rowe; Victor L Villemagne
Brain amyloid imaging.
Journal of nuclear medicine technology 2013;41(1):11-8.
2013: Akihiro Takano; Nabil Al Tawil; Andrea Thiele; Andrea Varrone; Victor L Villemagne; Torsten Zimmermann; Balázs Gulyás; Jan Hillert; Anja Hoffmann; Thomas Kucinski; Richard Macdonell; Sangram Nag; Fredrik Piehl; Christopher C Rowe; Marcus Schultze-Mosgau; Per Stenkrona; Christer Halldin
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
EJNMMI research 2013;3(1):30.
2013: James R Burrell; Michael Hornberger; Christopher C Rowe; Victor L Villemagne; John R Hodges
Clinical profile of PiB-positive corticobasal syndrome.
PloS one 2013;8(4):e61025.
2013: K Abigail Andrews; Josephine Barnes; M Jorge Cardoso; Nick C Fox; Kelvin K Leung; Kate E Macdonald; Marc Modat; Sebastien Ourselin; Christopher C Rowe; Jonathan M Schott; Victor L Villemagne; Tom Yeatman
Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials.
PloS one 2013;8(3):e58816.
2013: S Frost; Yogesan Kanagasingam; Ralph N Martins; Colin L Masters; S Rainey-Smith; Christopher C Rowe; O Salvado; H Sohrabi; Cassandra E I Szoeke; J Vignarajan; Victor L Villemagne; S Lance Macaulay; David Ames; Pierrick Bourgeat; Kathryn A Ellis
Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.
Translational psychiatry 2013;3():e233.
2013: Kathryn A Ellis; Karra Harrington; Yen Ying Lim; Ralph N Martins; Paul Maruff; Colin L Masters; Christopher C Rowe; Greg Savage; Cassandra E I Szoeke; Victor L Villemagne; David Ames; Ashley I Bush; David Darby
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
Journal of Alzheimer's disease : JAD 2013;34(4):861-71.
2013: Alan Rembach; Blaine R Roberts; Christopher C Rowe; Rebecca L Rumble; Brett O Trounson; Victor L Villemagne; Irene Volitakis; Andrew D Watt; William Wilson; James D Doecke; Kathryn A Ellis; Noel G Faux; Christopher J Fowler; Ralph N Martins; Colin L Masters; Kelly K Pertile; David Ames; Ashley I Bush
Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2013;34(1):171-82.
2013: Yen Ying Lim; Ralph N Martins; David Ames; Ashley I Bush; David Darby; Kathryn A Ellis; Joanne Gale; Karra Harrington; Colin L Masters; Robert H Pietrzak; Christopher C Rowe; Greg Savage; Cassandra E I Szoeke; Victor L Villemagne; Paul Maruff
Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?
Journal of Alzheimer's disease : JAD 2013;33(4):1167-76.
2013: Alex Bahar-Fuchs; Gaël Chetélat; Fiona Lamb; Kevin Ong; Cornelia B Reininger; Victor L Villemagne; Michael Woodward; Christopher C Rowe
Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests.
Journal of Alzheimer's disease : JAD 2013;33(2):451-62.
2013: Yen Ying Lim; Ralph N Martins; David Ames; Tim Ashwood; Ashley I Bush; David Darby; Kathryn A Ellis; Karra Harrington; Judith Jaeger; Colin L Masters; Robert H Pietrzak; Christopher C Rowe; Cassandra E I Szoeke; Victor L Villemagne; Paul Maruff
Rapid decline in episodic memory in healthy older adults with high amyloid-β.
Journal of Alzheimer's disease : JAD 2013;33(3):675-9.
2013: Victor L Villemagne; Christopher C Rowe
Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2013;33 Suppl 1():S349-59.
2013: Andrew D Watt; Victor L Villemagne; Kevin J Barnham
Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?
Journal of Alzheimer's disease : JAD 2013;33 Suppl 1():S283-93.
2012: Yen Ying Lim; Ralph N Martins; Paul Maruff; Colin L Masters; Robert H Pietrzak; Christopher C Rowe; Greg Savage; Cassandra E I Szoeke; Victor L Villemagne; David Ames; David Darby; Kathryn A Ellis; Karra Harrington
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.
Neurology 2012;79(16):1645-52.
2012: Michelle T Fodero-Tavoletti; Sabine Krause; Lucas Martin; Colin L Masters; Catriona A McLean; Christopher C Rowe; Andrea Thiele; Victor L Villemagne; Mathias Berndt; Damian Brockschnieder; Andrea R Connor; Ludger M Dinkelborg; Thomas Dyrks; Roberto Cappai
In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer.
Nuclear medicine and biology 2012;39(7):1042-8.
2012: John M Ringman; David B Teplow; Victor L Villemagne
The exception makes the rule: not all Aβ plaques are created equal.
Neurology 2012;79(3):206-7.
2012: Nicolas Villain; Victor L Villemagne; David Ames; Pierrick Bourgeat; Gaël Chételat; Kathryn A Ellis; Francis Eustache; Blandine Grassiot; Gareth Jones; Ralph N Martins; Colin L Masters; Christopher C Rowe; Olivier Salvado
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Brain : a journal of neurology 2012;135(Pt 7):2126-39.
2012: Victor L Villemagne; Kenneth Young; Henri Tochon-Danguy; J Gordon Chan; Gareth Jones; Colin L Masters; Rachel S Mulligan; Graeme O'Keefe; Kevin Ong; Svetlana Pejoska; Christopher C Rowe
Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease.
European journal of nuclear medicine and molecular imaging 2012;39(6):983-9.
2012: John V Ly; Henry Ma; Graeme O'Keefe; Christopher C Rowe; Ramesh Sahathevan; Tim Saunder; Henri Tochon-Danguy; Victor L Villemagne; Jorge A Zavala; Uwe Ackerman; Leonid Churilov; Sylvia J Gong; Rico Gunawan; Geoffrey A Donnan
Subacute ischemic stroke is associated with focal 11C PiB positron emission tomography retention but not with global neocortical Aβ deposition.
Stroke; a journal of cerebral circulation 2012;43(5):1341-6.
2012: Lin W Hung; Su Ling Leong; SinChun Lim; Xiang Liu; Colin L Masters; Graeme O'Keefe; Chi L L Pham; Andrew K Powell; Blaine R Roberts; David M Shackleford; Nicki A Sherratt; Victor L Villemagne; Anthony R White; Simon Wilkins; Ashley I Bush; Roberto Cappai; Lesley Cheng; Robert A Cherny; Francis C K Chiu; Peter J Crouch; Janetta G Culvenor; Paul S Donnelly; David Finkelstein; Jessica George; Andrew F Hill; Scott Ayton; Kevin J Barnham
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.
The Journal of experimental medicine 2012;209(4):837-54.
2012: Oscar Acosta; David Ames; Vincent Barra; Erik Bonner; Pierrick Bourgeat; Gaël Chételat; Vincent Doré; Kathryn A Ellis; Jean-Marie Favreau; Jurgen Fripp; Florence Gris; Ralph N Martins; Colin L Masters; Parnesh Raniga; Christopher C Rowe; Andrea Rueda; Cassandra Szoeke; Victor L Villemagne; Di Xiao; Olivier Salvado
Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease.
Journal of neuroscience methods 2012;205(1):96-109.
2012: Gaël Chételat; Kathryn A Ellis; G Jones; Ralph N Martins; C L Masters; Christopher C Rowe; Nicolas Villain; Victor L Villemagne; D Ames
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition.
Neurology 2012;78(7):477-84.
2012: Victor L Villemagne; Michael W Weiner; David J Brooks; Bradley T Hyman; Milos D Ikonomovic; Kenji Ishii; Clifford R Jack; William J Jagust; Keith A Johnson; William E Klunk; Robert A Koeppe; Val J Lowe; Colin L Masters; Chester A Mathis; Thomas J Montine; John C Morris; Agneta Nordberg; Ronald C Petersen; Eric M Reiman; Christopher C Rowe; Dennis J Selkoe; Reisa A Sperling; Koen Van Laere; Alexander Drzezga
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.
European journal of nuclear medicine and molecular imaging 2012;39(2):209-19.
2012: Luping Zhou; Pierrick Bourgeat; Vincent Dore; Jurgen Fripp; Parnesh Raniga; Christopher C Rowe; Olivier Salvado; Victor L Villemagne
MR-less surface-based amyloid estimation by subject-specific atlas selection and Bayesian fusion.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2012;15(Pt 2):220-7.
2012: Andrew D Watt; Colin L Masters; Keyla Perez; Alan R Rembach; Victor L Villemagne; Kevin J Barnham
Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing.
Journal of Alzheimer's disease : JAD 2012;30(2):323-36.
2012: Gaël Chételat; Kathryn A Ellis; Colin L Masters; Kerryn E Pike; Christopher C Rowe; Victor L Villemagne; David Ames
Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease.
Neuro-degenerative diseases 2012;10(1-4):141-4.
2012: Victor L Villemagne; Daniel M Skovronsky; Gaël Chételat; John Drago; Gareth Jones; Hank F Kung; Colin L Masters; Rachel S Mulligan; Nobuyuki Okamura; Graeme O'Keefe; Svetlana Pejoska; Michael Pontecorvo; Christopher C Rowe
Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
Neuro-degenerative diseases 2012;10(1-4):161-5.
2011: Christopher C Rowe; Victor L Villemagne
Brain amyloid imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(11):1733-40.
2011: Cristian E Leyton; Olivier Piguet; Kerryn E Pike; Christopher C Rowe; Sharon Savage; Victor L Villemagne; Kirrie J Ballard; James R Burrell; John R Hodges
Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
Brain : a journal of neurology 2011;134(Pt 10):3030-43.
2011: Victor L Villemagne; Christopher C Rowe
Amyloid imaging.
International psychogeriatrics / IPA 2011;23 Suppl 2():S41-9.
2011: Michelle T Fodero-Tavoletti; Colin L Masters; Christopher C Rowe; Victor L Villemagne; Kevin J Barnham; Roberto Cappai
Amyloid-β: the seeds of darkness.
The international journal of biochemistry & cell biology 2011;43(9):1247-51.
2011: Victor L Villemagne; Henri Tochon-Danguy; Uwe Ackerman; J Gordon Chan; Lueder Fels; Gerhard Holl; Gareth Jones; Colin L Masters; Rachel S Mulligan; Graeme O'Keefe; Kevin Ong; Svetlana Pejoska; Barbara Putz; Cornelia B Reininger; Beate Rohde; Christopher C Rowe
Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1210-7.
2011: P A Yates; S Farquharson; Colin L Masters; Christopher C Rowe; R Sirisriro; Victor L Villemagne
Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease.
Neurology 2011;77(1):48-54.
2011: Victor L Villemagne; Daniel M Skovronsky; Henri Tochon-Danguy; Uwe Ackermann; Gaël Chételat; John Drago; Sylvia Gong; Gareth Jones; Hank F Kung; Colin L Masters; Rachel S Mulligan; Nobuyuki Okamura; Graeme J O'Keefe; Svetlana Pejoska; Christopher C Rowe
In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.
Archives of neurology 2011;68(7):905-12.
2011: Kerryn E Pike; Cassandra Szoeke; Giuseppe Verdile; Victor L Villemagne; David Ames; Gael Chételat; Kathryn A Ellis; Norm Good; Simon M Laws; Ralph N Martins; Colin L Masters; Christopher C Rowe
Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study.
Neuropsychologia 2011;49(9):2384-90.
2011: Michelle T Fodero-Tavoletti; Nobuyuki Okamura; Shozo Furumoto; Rachel S Mulligan; Andrea R Connor; Catriona A McLean; Diana Cao; Angela Rigopoulos; Glenn A Cartwright; Graeme J O'Keefe; Sylvia Gong; Paul A Adlard; Kevin J Barnham; Christopher C Rowe; Colin L Masters; Yukitsuka Kudo; Roberto Cappai; Kazuhiko Yanai; Victor L Villemagne
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.
Brain : a journal of neurology 2011;134(Pt 4):1089-100.
2011: V B Gupta; Simon Laws; Victor L Villemagne; D Ames; Ashley I Bush; K A Ellis; J K Lui; Colin L Masters; Christopher C Rowe; C Szoeke; Kevin Taddei; Ralph N Martins
Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.
Neurology 2011;76(12):1091-8.
2011: Gaël Chételat; Victor L Villemagne; Kerryn E Pike; Kathryn A Ellis; Pierrick Bourgeat; Gareth Jones; Graeme J O'Keefe; Olivier Salvado; Cassandra Szoeke; Ralph N Martins; David Ames; Colin L Masters; Christopher C Rowe
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Brain : a journal of neurology 2011;134(Pt 3):798-807.
2011: Kathryn A Ellis; Christopher C Rowe; Cassandra E I Szoeke; Victor L Villemagne; David Ames; Gaël Chételat; Ralph N Martins; Colin L Masters; Jurgen Fripp; Oscar Acosta; Parnesh Raniga; Pierrick T Bourgeat; Olivier Salvado
Advances in structural and molecular neuroimaging in Alzheimer's disease.
The Medical journal of Australia 2011;194(4):S20-3.
2011: David G Darby; Amy Fredrickson; Julia Fredrickson; Paul Maruff; Robert H Pietrzak; Victor L Villemagne; Michael Woodward; Amy Brodtmann; Christopher C Rowe
Episodic memory decline predicts cortical amyloid status in community-dwelling older adults.
Journal of Alzheimer's disease : JAD 2011;27(3):627-37.
2011: Nastasia K-H Lim; Colin L Masters; Catriona A McLean; Christopher C Rowe; Cynthia P W Soon; Victor L Villemagne; Geneviève Evin; Katrina M Laughton; Qiao-Xin Li
Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2011;26(4):779-86.
2011: Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme J O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
Annals of neurology 2011;69(1):181-92.
2011: Andrew D Watt; Keyla Perez; Noel G Faux; Kerryn E Pike; Christopher C Rowe; Pierrick Bourgeat; Olivier Salvado; Colin L Masters; Victor L Villemagne; Kevin J Barnham
Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2011;24(1):47-59.
2011: Victor L Villemagne; Graeme O'Keefe; Rachel S Mulligan; Christopher C Rowe
Quantitative approaches to amyloid imaging.
Methods in molecular biology (Clifton, N.J.) 2011;680():201-25.
2010: John V Ly; Christopher C Rowe; Victor L Villemagne; Jorge A Zavala; Henry Ma; Graeme J O'Keefe; Sylvia J Gong; Rico Gunawan; Leonid Churilov; Tim Saunder; Uwe Ackerman; Henri Tochon-Danguy; Geoffrey A Donnan
Cerebral β-amyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage.
Annals of neurology 2010;68(6):959-62.
2010: Gaël Chételat; Victor L Villemagne; Kerryn E Pike; Jean-Claude Baron; Pierrick Bourgeat; Gareth Jones; Noel G Faux; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; Ralph N Martins; David Ames; Colin L Masters; Christopher C Rowe
Larger temporal volume in elderly with high versus low beta-amyloid deposition.
Brain : a journal of neurology 2010;133(11):3349-58.
2010: Sinchun Lim; Brett M Paterson; Michelle T Fodero-Tavoletti; Graeme J O'Keefe; Roberto Cappai; Kevin J Barnham; Victor L Villemagne; Paul S Donnelly
A copper radiopharmaceutical for diagnostic imaging of Alzheimer's disease: a bis(thiosemicarbazonato)copper(II) complex that binds to amyloid-beta plaques.
Chemical communications (Cambridge, England) 2010;46(30):5437-9.
2010: Christopher C Rowe; Kathryn A Ellis; Miroslava Rimajova; Pierrick Bourgeat; Kerryn E Pike; Gareth Jones; Jurgen Fripp; Henri Tochon-Danguy; Laurence Morandeau; Graeme O'Keefe; Roger Price; Parnesh Raniga; Peter Robins; Oscar Acosta; Nat Lenzo; Cassandra Szoeke; Olivier Salvado; Richard Head; Ralph Martins; Colin L Masters; David Ames; Victor L Villemagne
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
Neurobiology of aging 2010;31(8):1275-83.
2010: Victor L Villemagne; Keyla Perez; Kerryn E Pike; W Mei Kok; Christopher C Rowe; Anthony R White; Pierrick Bourgeat; Olivier Salvado; Justin Bedo; Craig A Hutton; Noel G Faux; Colin L Masters; Kevin J Barnham
Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(18):6315-22.
2010: Kathryn A Ellis; Christopher C Rowe; Victor L Villemagne; Ralph N Martins; Colin L Masters; Olivier Salvado; Cassandra Szoeke; David Ames
Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2010;6(3):291-6.
2010: Gaël Chételat; Victor L Villemagne; Pierrick Bourgeat; Kerryn E Pike; Gareth Jones; David Ames; Kathryn A Ellis; Cassandra Szoeke; Ralph N Martins; Graeme J O'Keefe; Olivier Salvado; Colin L Masters; Christopher C Rowe
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.
Annals of neurology 2010;67(3):317-24.
2010: J V Ly; Geoffrey A Donnan; Victor L Villemagne; J A Zavala; H Ma; Graeme J O'Keefe; Sylvia J Gong; R M Gunawan; Tim Saunder; U Ackerman; Henri Tochon-Danguy; L Churilov; Thanh G Phan; Christopher C Rowe
11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage.
Neurology 2010;74(6):487-93.
2010: Nobuyuki Okamura; Victor L Villemagne; John Drago; Svetlana Pejoska; Rajinder K Dhamija; Rachel S Mulligan; Julia R Ellis; Uwe Ackermann; Graeme O'Keefe; Gareth Jones; Hank F Kung; Michael J Pontecorvo; Daniel Skovronsky; Christopher C Rowe
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(2):223-8.
2010: Pierrick Bourgeat; G Chételat; Victor L Villemagne; Jurgen Fripp; Parnesh Raniga; K Pike; O Acosta; C Szoeke; Sébastien Ourselin; D Ames; K A Ellis; R N Martins; Colin L Masters; Christopher C Rowe; O Salvado
Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
Neurology 2010;74(2):121-7.
2010: Alex Bahar-Fuchs; Gaël Chételat; Victor L Villemagne; Simon Moss; Kerryn Pike; Colin L Masters; Christopher C Rowe; Greg Savage
Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study.
Journal of Alzheimer's disease : JAD 2010;22(4):1081-7.
2010: James K Lui; Simon Laws; Qiao-Xin Li; Victor L Villemagne; David Ames; Belinda Brown; Ashley I Bush; Karl De Ruyck; Jasmin Dromey; Kathryn A Ellis; Noel G Faux; Jonathan Foster; Christopher Fowler; Veer Gupta; Peter Hudson; Katrina Laughton; Colin L Masters; Kelly Pertile; Alan Rembach; Mira Rimajova; Mark Rodrigues; Christopher C Rowe; Rebecca Rumble; Cassandra Szoeke; Kevin Taddei; Tania Taddei; Brett Trounson; Vanessa Ward; Ralph N Martins
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.
Journal of Alzheimer's disease : JAD 2010;20(4):1233-42.
2010: Michelle T Fodero-Tavoletti; Victor L Villemagne; Brett M Paterson; Anthony R White; Qiao-Xin Li; James Camakaris; Graeme O'Keefe; Roberto Cappai; Kevin J Barnham; Paul S Donnelly
Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2010;20(1):49-55.
2010: Victor L Villemagne; Kerryn Pike; Svetlana Pejoska; Alison Boyd; Margaret Power; Gareth Jones; Colin L Masters; Christopher C Rowe
11C-PiB PET ABri imaging in Worster-Drought syndrome (familial British dementia): a case report.
Journal of Alzheimer's disease : JAD 2010;19(2):423-8.
2009: Victor L Villemagne; Suzuka Ataka; Toshiki Mizuno; William S Brooks; Yasuhiro Wada; Masaki Kondo; Gareth Jones; Yasuyoshi Watanabe; Rachel Mulligan; Masanori Nakagawa; Takami Miki; Hiroyuki Shimada; Graeme J O'Keefe; Colin L Masters; Hiroshi Mori; Christopher C Rowe
High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.
Archives of neurology 2009;66(12):1537-44.
2009: Nobuyuki Okamura; Christopher C Rowe; Kazuhiko Yanai; Hiroyuki Arai; Michelle T Fodero-Tavoletti; Shozo Furumoto; Yukitsuka Kudo; Colin L Masters; Victor L Villemagne
Advances in molecular imaging for the diagnosis of dementia.
Expert opinion on medical diagnostics 2009;3(6):705-16.
2009: Seok Ming Lim; Andrew Katsifis; Victor L Villemagne; Rene Best; Gareth Jones; Michael Saling; Jennifer Bradshaw; John Merory; Michael Woodward; Malcolm Hopwood; Christopher C Rowe
The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(10):1638-45.
2009: Michelle T Fodero-Tavoletti; Colin L Masters; Catriona A McLean; Kerryn E Pike; Christopher C Rowe; Paul A Adlard; Roberto Cappai; Andrea R Connor; Tiffany Cowie; Victor L Villemagne
Amyloid imaging in Alzheimer's disease and other dementias.
Brain imaging and behavior 2009;3(3):246-61.
2009: Michelle T Fodero-Tavoletti; Rachel S Mulligan; Nobuyuki Okamura; Shozo Furumoto; Christopher C Rowe; Yukitsuka Kudo; Colin L Masters; Roberto Cappai; Kazuhiko Yanai; Victor L Villemagne
In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
European journal of pharmacology 2009;617(1-3):54-8.
2009: J R Ellis; Pradeep Nathan; Victor L Villemagne; R S Mulligan; Kathryn A Ellis; H J Tochon-Danguy; J G Chan; G J O'keefe; J Bradley; Greg Savage; Christopher C Rowe
The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380.
Synapse (New York, N.Y.) 2009;63(9):752-63.
2009: Victor L Villemagne; Catriona A McLean; K Reardon; A Boyd; V Lewis; G Klug; G Jones; D Baxendale; Colin L Masters; Christopher C Rowe; S J Collins
11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.
Journal of neurology, neurosurgery, and psychiatry 2009;80(9):998-1001.
2009: Kathryn A Ellis; Ashley I Bush; David Darby; Daniela De Fazio; Jonathan Foster; Peter Hudson; Nicola T Lautenschlager; Nat Lenzo; Ralph N Martins; Paul Maruff; Colin L Masters; Andrew Milner; Kerryn Pike; Christopher C Rowe; Greg Savage; Cassandra Szoeke; Kevin Taddei; Victor L Villemagne; Michael Woodward; David Ames
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
International psychogeriatrics / IPA 2009;21(4):672-87.
2009: Graeme J O'Keefe; Timothy H Saunder; Steven Ng; Uwe Ackerman; Henri J Tochon-Danguy; J Gordon Chan; Sylvia Gong; Thomas Dyrks; Stefanie Lindemann; Gerhard Holl; Ludger Dinkelborg; Victor L Villemagne; Christopher C Rowe
Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(2):309-15.
2009: Michelle T Fodero-Tavoletti; Christopher C Rowe; Catriona A McLean; Laura Leone; Qiao-Xin Li; Colin L Masters; Roberto Cappai; Victor L Villemagne
Characterization of PiB binding to white matter in Alzheimer disease and other dementias.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(2):198-204.
2009: J R Ellis; Pradeep Nathan; Victor L Villemagne; R S Mulligan; T Saunder; K Young; C L Smith; J Welch; M Woodward; Keith A Wesnes; Greg Savage; Christopher C Rowe
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.
Psychopharmacology 2009;202(1-3):79-91.
2008: P Edison; Christopher C Rowe; J O Rinne; S Ng; I Ahmed; N Kemppainen; Victor L Villemagne; G O'Keefe; K Någren; K R Chaudhury; Colin L Masters; David J Brooks
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 2008;79(12):1331-8.
2008: Jurgen Fripp; Pierrick Bourgeat; Oscar Acosta; Parnesh Raniga; Marc Modat; Kerryn E Pike; Gareth Jones; Graeme O'Keefe; Colin L Masters; David Ames; Kathryn A Ellis; Paul Maruff; Jon Currie; Victor L Villemagne; Christopher C Rowe; Olivier Salvado; Sébastien Ourselin
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging.
NeuroImage 2008;43(3):430-9.
2008: Parnesh Raniga; Pierrick Bourgeat; Jurgen Fripp; Oscar Acosta; Victor L Villemagne; Christopher C Rowe; Colin L Masters; Gareth Jones; Graeme O'Keefe; Olivier Salvado; Sébastien Ourselin
Automated (11)C-PiB standardized uptake value ratio.
Academic radiology 2008;15(11):1376-89.
2008: J R Ellis; Victor L Villemagne; P J Nathan; R S Mulligan; S J Gong; J G Chan; J Sachinidis; Graeme J O'Keefe; Kunthi Pathmaraj; K A Wesnes; G Savage; Christopher C Rowe
Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.
Neurobiology of learning and memory 2008;90(2):404-12.
2008: Victor L Villemagne; Michelle T Fodero-Tavoletti; Kerryn E Pike; Roberto Cappai; Colin L Masters; Christopher C Rowe
The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.
Molecular neurobiology 2008;38(1):1-15.
2008: Christopher C Rowe; Uwe Ackerman; William Browne; Rachel Mulligan; Kerryn L Pike; Graeme J O'Keefe; Henri Tochon-Danguy; Gordon Chan; Salvatore U Berlangieri; Gareth Jones; Kerryn L Dickinson-Rowe; Hank P Kung; Wei Zhang; Mei Ping Kung; Daniel Skovronsky; Thomas Dyrks; Gerhard Holl; Sabine Krause; Matthias Friebe; Lutz Lehman; Stefanie Lindemann; Ludger M Dinkelborg; Colin L Masters; Victor L Villemagne
Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.
Lancet neurology 2008;7(2):129-35.
2008: Jurgen Fripp; Pierrick Bourgeat; Parnesh Raniga; Oscar Acosta; Victor L Villemagne; Gareth Jones; Graeme O'keefe; Christopher C Rowe; Sébastien Ourselin; Olivier Salvado
MR-less high dimensional spatial normalization of 11C PiB PET images on a population of elderly, mild cognitive impaired and Alzheimer disease patients.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2008;11(Pt 1):442-9.
2008: Victor L Villemagne; K E Pike; D Darby; Paul Maruff; G Savage; Steven Ng; U Ackermann; T F Cowie; J Currie; S G Chan; G Jones; Henri Tochon-Danguy; G O'Keefe; Colin L Masters; Christopher C Rowe
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
Neuropsychologia 2008;46(6):1688-97.
2007: Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.
Brain : a journal of neurology 2007;130(Pt 11):2837-44.
2007: Michelle T Fodero-Tavoletti; David P Smith; Catriona A McLean; Paul A Adlard; Kevin J Barnham; Lisa E Foster; Laura Leone; Keyla Perez; Mikhalina Cortés; Janetta G Culvenor; Qiao-Xin Li; Katrina M Laughton; Christopher C Rowe; Colin L Masters; Roberto Cappai; Victor L Villemagne
In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(39):10365-71.
2007: Steven Y Ng; Victor L Villemagne; Colin L Masters; Christopher C Rowe
Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
Archives of neurology 2007;64(8):1140-4.
2007: Christopher C Rowe; Steven Ng; U Ackermann; Sylvia J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; Paul Maruff; D Darby; C Smith; M Woodward; John R Merory; Henri Tochon-Danguy; Graeme J O'Keefe; William E Klunk; Chester A Mathis; J C Price; Colin L Masters; Victor L Villemagne
Imaging beta-amyloid burden in aging and dementia.
Neurology 2007;68(20):1718-25.
2007: Steven Ng; Victor L Villemagne; Salvatore U Berlangieri; Sze-Ting Lee; Martin Cherk; Sylvia J Gong; Uwe Ackermann; Tim Saunder; Henri Tochon-Danguy; Gareth Jones; Clare Smith; Graeme J O'Keefe; Colin L Masters; Christopher C Rowe
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):547-52.
2007: Parnesh Raniga; Pierrick Bourgeat; Victor L Villemagne; Graeme O'Keefe; Christopher C Rowe; Sébastien Ourselin
Spline based inhomogeneity correction for 11C-PIB PET segmentation using expectation maximization.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2007;10(Pt 1):228-35.
2006: Colin L Masters; Roberto Cappai; Kevin J Barnham; Victor L Villemagne
Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
Journal of neurochemistry 2006;97(6):1700-25.
2006: Carlos Opazo; Sandra Luza; Victor L Villemagne; Irene Volitakis; Christopher C Rowe; Kevin J Barnham; Dorothea Strozyk; Colin L Masters; Robert A Cherny; Ashley I Bush
Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.
Aging cell 2006;5(1):69-79.
2006: Andrew G Horti; Victor L Villemagne
The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain.
Current pharmaceutical design 2006;12(30):3877-900.
2005: Sascha Mitkovski; Victor L Villemagne; Kathy E Novakovic; Graeme J O'Keefe; Henri Tochon-Danguy; Rachel S Mulligan; Kerryn L Dickinson; Tim Saunder; Marie-Claude Gregoire; Michel Bottlaender; Frederic Dolle; Christopher C Rowe
Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.
Nuclear medicine and biology 2005;32(6):585-91.
2005: Victor L Villemagne; Christopher C Rowe; S Macfarlane; Kathy E Novakovic; Colin L Masters
Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2005;12(3):221-30.
2005: Kathy E Novakovic; Victor L Villemagne; Christopher C Rowe; Colin L Masters
Rare genetically defined causes of dementia.
International psychogeriatrics / IPA 2005;17 Suppl 1():S149-94.
2003: Chuanyong Bai; Paul E Kinahan; David Brasse; Claude Comtat; David W Townsend; Carolyn Meltzer; Victor L Villemagne; Martin Charron; Michel Defrise
An analytic study of the effects of attenuation on tumor detection in whole-body PET oncology imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(11):1855-61.
2003: June M Stapleton; Stephen F Gilson; Dean F Wong; Victor L Villemagne; Robert F Dannals; Roger F Grayson; Jack E Henningfield; Edythe D London
Intravenous nicotine reduces cerebral glucose metabolism: a preliminary study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(4):765-72.
2003: Carole Lartizien; Paul E Kinahan; Richard G Swensson; Claude Comtat; Michael Lin; Victor L Villemagne; Régine Trébossen
Evaluating image reconstruction methods for tumor detection in 3-dimensional whole-body PET oncology imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(2):276-90.
2002: Phil J Greer; Victor L Villemagne; James Ruszkiewicz; Angela K Graves; Carolyn Meltzer; Chester A Mathis; Julie C Price
MR atlas of the baboon brain for functional neuroimaging.
Brain research bulletin 2002;58(4):429-38.
2002: Patricia M Villemagne; Sakkubai Naidu; Victor L Villemagne; Myron Yaster; Henry N Wagner; James C Harris; Hugo W Moser; Michael V Johnston; Robert F Dannals; Dean F Wong
Brain glucose metabolism in Rett Syndrome.
Pediatric neurology 2002;27(2):117-22.
2002: Julie C Price; Wayne C Drevets; James Ruszkiewicz; Phil J Greer; Victor L Villemagne; Lei Xu; Sati Mazumdar; Michael N Cantwell; Chester A Mathis
Sequential H(2)(15)O PET studies in baboons: before and after amphetamine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(8):1090-100.
2001: Carolyn Meltzer; Douglas Kondziolka; Victor L Villemagne; Lawrence R Wechsler; S Goldstein; Keith R Thulborn; James Gebel; Elaine Elder; Sharon DeCesare; A Jacobs
Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke.
Neurosurgery 2001;49(3):586-91; discussion 591-2.
2001: Carolyn Cidis Meltzer; Wayne C Drevets; Julie C Price; Chester A Mathis; Brian J Lopresti; Phil J Greer; Victor L Villemagne; D Holt; N Scott Mason; Patricia R Houck; Charles F Reynolds; Steven T DeKosky
Gender-specific aging effects on the serotonin 1A receptor.
Brain research 2001;895(1-2):9-17.
2000: Martin Charron; Thomas Beyer; Nicolaas I Bohnen; Paul E Kinahan; MA Dachille; J Jerin; R Nutt; Carolyn Meltzer; Victor L Villemagne; David W Townsend
Image analysis in patients with cancer studied with a combined PET and CT scanner.
Clinical nuclear medicine 2000;25(11):905-10.
2000: Martin G Pomper; John L Musachio; Ursula Scheffel; JE MacDonald; Dennis J McCarthy; DW Reif; Victor L Villemagne; Fuji Yokoi; Robert F Dannals; Dean F Wong
Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(8):1417-25.
2000: Eric A Nofzinger; Julie C Price; Carolyn Meltzer; Daniel J Buysse; Victor L Villemagne; Jean M Miewald; Robert C Sembrat; D A Steppe; David J Kupfer
Towards a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep.
Psychiatry research 2000;98(2):71-91.
1999: Victor L Villemagne; Dean F Wong; Fuji Yokoi; Massoud Stephane; K C Rice; D Matecka; D J Clough; Robert F Dannals; R B Rothman
GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
Synapse (New York, N.Y.) 1999;33(4):268-73.
1999: Victor L Villemagne; R B Rothman; Fuji Yokoi; K C Rice; D Matecka; Robert F Dannals; Dean F Wong
Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
Synapse (New York, N.Y.) 1999;32(1):44-50.
1999: John L Musachio; Victor L Villemagne; Ursula Scheffel; Robert F Dannals; A. Semih Dogan; Fuji Yokoi; Dean F Wong
Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon.
Nuclear medicine and biology 1999;26(2):201-7.
1999: Evan D Morris; Svetlana I Chefer; Mark A Lane; Raymond F Muzic; Dean F Wong; Robert F Dannals; John A Matochik; Ali A Bonab; Victor L Villemagne; Steven J Grant; Donald Ingram; George S Roth; Edythe D London
Loss of D2 receptor binding with age in rhesus monkeys: importance of correction for differences in striatal size.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999;19(2):218-29.
1998: Una D McCann; Dean F Wong; Fuji Yokoi; Victor L Villemagne; Robert F Dannals; George A Ricaurte
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(20):8417-22.
1998: P M Sánchez-Roa; Henry N Wagner; Victor L Villemagne; Edythe D London; John R Lever
Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probe.
European journal of pharmacology 1998;358(3):207-11.
1998: T Mochizuki; Victor L Villemagne; Ursula Scheffel; Robert F Dannals; PA Finley; Y Zhan; Henry N Wagner; John L Musachio
Nicotine induced up-regulation of nicotinic receptors in CD-1 mice demonstrated with an in vivo radiotracer: gender differences.
Synapse (New York, N.Y.) 1998;30(1):116-8.
1998: Victor L Villemagne; Jie Yuan; Dean F Wong; Robert F Dannals; George Hatzidimitriou; William B Mathews; Hayden T Ravert; John L Musachio; Una D McCann; George A Ricaurte
Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(1):419-27.
1998: Dean F Wong; George A Ricaurte; Gerhard Gründer; Richard E Rothman; Sakkubai Naidu; Harvey S Singer; James C Harris; Fuji Yokoi; Victor L Villemagne; Sally Szymanski; Albert Gjedde; Michael J Kuhar
Dopamine transporter changes in neuropsychiatric disorders.
Advances in pharmacology (San Diego, Calif.) 1998;42():219-23.
1997: Victor L Villemagne; Andrew G Horti; Ursula Scheffel; Hayden T Ravert; PA Finley; D J Clough; Edythe D London; Henry N Wagner; Robert F Dannals
Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(11):1737-41.
1997: S Kim; Henry N Wagner; Victor L Villemagne; PF Kao; Robert F Dannals; Hayden T Ravert; T Joh; R B Dixon; A Cahid Civelek
Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(11):1726-31.
1997: T Mochizuki; Victor L Villemagne; Ursula Scheffel; X Liu; John L Musachio; Robert F Dannals; Henry N Wagner
A simple probe measures the pharmacokinetics of[125I]RTI-55 in mouse brain in vivo.
European journal of pharmacology 1997;338(1):17-23.
1997: John L Musachio; Victor L Villemagne; Ursula Scheffel; M Stathis; PA Finley; Andrew G Horti; Edythe D London; Robert F Dannals
[125/123I]IPH: a radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors.
Synapse (New York, N.Y.) 1997;26(4):392-9.
1996: S Grant; Edythe D London; David B Newlin; Victor L Villemagne; Xinhe Liu; C Contoreggi; R L Phillips; Alane S Kimes; A Margolin
Activation of memory circuits during cue-elicited cocaine craving.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):12040-5.
1996: Victor L Villemagne; R L Phillips; Xinhe Liu; S F Gilson; Robert F Dannals; Dean F Wong; P J Harris; M Ruff; C Pert; P Bridge; Edythe D London
Peptide T and glucose metabolism in AIDS dementia complex.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(7):1177-80.
1996: Edythe D London; J M Stapleton; R L Phillips; Steven J Grant; Victor L Villemagne; Xinhe Liu; R Soria
PET studies of cerebral glucose metabolism: acute effects of cocaine and long-term deficits in brains of drug abusers.
NIDA research monograph 1996;163():146-58.
1995: Xinhe Liu; R L Phillips; S M Resnick; Victor L Villemagne; Dean F Wong; J M Stapleton; Edythe D London
Magnetic resonance imaging reveals no ventriculomegaly in polydrug abusers.
Acta neurologica Scandinavica 1995;92(1):83-90.
1994: Victor L Villemagne; J James Frost; Robert F Dannals; John R Lever; S Tanada; T K Natarajan; Alan Wilson; Hayden T Ravert; Henry N Wagner
Comparison of [11C]diprenorphine and [11C]carfentanil in vivo binding to opiate receptors in man using a dual detector system.
European journal of pharmacology 1994;257(1-2):195-7.
1992: Dean F Wong; Alan Wilson; C Chen; E Minkin; Robert F Dannals; Hayden T Ravert; P Sanchez-Roa; Victor L Villemagne; Henry N Wagner
In vivo studies of [125I]iodobenzamide and [11C]iodobenzamide: a ligand suitable for positron emission tomography and single photon emission tomography imaging of cerebral D2 dopamine receptors.
Synapse (New York, N.Y.) 1992;12(3):236-41.
1991: Victor L Villemagne; Robert F Dannals; P M Sánchez-Roa; Hayden T Ravert; S Vazquez; Alan Wilson; T K Natarajan; Dean F Wong; K Yanai; Henry N Wagner
Imaging histamine H1 receptors in the living human brain with carbon-11-pyrilamine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(2):308-11.
1991: Victor L Villemagne; P M Sánchez Roa
[Introduction to positron emission tomography].
Medicina 1991;51(1):62-70.
1990: M Suehiro; Robert F Dannals; Ursula Scheffel; M Stathis; Alan Wilson; Hayden T Ravert; Victor L Villemagne; P M Sanchez-Roa; Henry N Wagner
In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(12):2015-21.
1989: P M Sánchez-Roa; D E Grigoriadis; Alan Wilson; John Sharkey; Robert F Dannals; Victor L Villemagne; Dean F Wong; Henry N Wagner; Michael J Kuhar
[125]I-spectramide: a novel benzamide displaying potent and selective effects at the D2 dopamine receptor.
Life sciences 1989;45(19):1821-9.
1988: Dean F Wong; E P Broussolle; Gary S Wand; Victor L Villemagne; Robert F Dannals; Jonathan M Links; Howard Zacur; James C Harris; Sakkubai Naidu; C Braestrup
In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences.
Annals of the New York Academy of Sciences 1988;515():203-14.
1987: Dean F Wong; John R Lever; P R Hartig; Robert F Dannals; Victor L Villemagne; B J Hoffman; Alan Wilson; Hayden T Ravert; Jonathan M Links; Ursula Scheffel
Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
Synapse (New York, N.Y.) 1987;1(5):393-8.